SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Continental Home Healthcare -A Demographic Play -- Ignore unavailable to you. Want to Upgrade?


To: Garth Richmond who wrote (59)7/4/2000 6:51:53 PM
From: Edward W. Richmond  Respond to of 69
 
"By the way, I don't understand how the EPS and fully diluted EPS are only 10% different when the warrants represent a much larger percentage. Any idea?"

I contacted management with that very question. I am awaiting an answer. However, apparently the warrants are not necessarily dilutive if the exercise price is above a certain number. I think the calculation of this number includes shareholder equity per share and a number of other items. I'll post the information when I get it.
Regards, Ed



To: Garth Richmond who wrote (59)7/6/2000 8:40:34 PM
From: Edward W. Richmond  Read Replies (1) | Respond to of 69
 
Garth, I finally have an answer to the question of potential dilution caused by the outstanding $0.60 warrants.
If the contribution from the exercising of the warrants is equal to or greater than the shareholder equity per share, the exercising is not dilutive. Also, if the normal bank interest on the exercise price is equal to or greater than the current earnings per share, the exercise is not considered dilutive. Thus the warrants are not included in fully diluted earnings per share.
Hope that helps.
Ed